Results 81 to 90 of about 2,893,372 (329)

Incidence trends and relative survival of colorectal neuroendocrine neoplasms: A population‐based study using German cancer registry data

International Journal of Cancer, Volume 157, Issue 1, Page 116-125, 1 July 2025.
What's new? This study used data from all 16 German cancer registries for colorectal neuroendocrine neoplasms to calculate incidence and relative survival. The data allowed differentiation by primary site, morphology (well‐differentiated neuroendocrine tumors—NETs, poorly differentiated neuroendocrine carcinomas—NECs and mixed neuroendocrine‐non ...
Lennart Möller, Andras Szentkirályi, Christine Eisfeld, Ina Wellmann, Franziska Rees, Kevin Claaßen, Florian Oesterling, Hiltraud Kajüter, Andreas Stang   +8 more
wiley   +1 more source

Case Report: Neuroendocrine Tumor With Cardiac Metastasis

Frontiers in Cardiovascular Medicine, 2020
Neuroendocrine tumors (NETs), also known as carcinoid tumors, are a heterogeneous group of neoplasms that arise from cells throughout the neuroendocrine system, most commonly arising from the gastrointestinal (GI) tract, lungs, and bronchi.
Rachel E. Kinney, Robert Decker, Deborah Sundlof, Muhammad A. Rizvi, Kelly Schadler   +4 more
doaj   +1 more source

Evaluation of radiological and clinical efficacy of ^{90}Y-DOTATATE} therapy in patients with progressive metastatic midgut neuroendocrine carcinomas [PDF]

, 2009
Background: To evaluate the radiological and clinical therapeutic effectiveness of ^{90}Y-octreotate [DOTATATE] inpatients with progressive somatostatin receptor-positive midgut neuroendocrine carcinomas (GEPNETs).
Buscombe, John R., Cwikła, Jaroslaw B., Jeziorski, Krzysztof G., Mikolajczak, Renata, Nasierowska-Guttmejer, Anna, Pawlak, Dariusz, Sankowski, Artur, Walecki, Jerzy   +7 more
core  

Predictors of Mortality in Patients With Multiple Endocrine Neoplasia Type 1

Clinical Endocrinology, Volume 103, Issue 1, Page 50-56, July 2025.
SUMMARY Objective Multiple Endocrine Neoplasia Type 1 (MEN 1) is an autosomal dominant disease predisposing to hyperplasia and neoplasia in diverse endocrine tissues. Patients typically present with endocrine abnormalities before the age of 30 years and have reduced life expectancy.
Jasmine J. Zhu, John R Burgess
wiley   +1 more source

Metabolic Signatures of Lung Cancer in Biofluids: NMR-Based Metabonomics of Blood Plasma [PDF]

, 2011
In this work, the variations in the metabolic profile of blood plasma from lung cancer patients and healthy controls were investigated through NMR-based metabonomics, to assess the potential of this approach for lung cancer screening and diagnosis.
Ana Gomes, Ana M. Gil, António S. Barros, Asiago V. M., Bathe O. F., Bell J. D., Brian J. Goodfellow, Brière J.-J., Carrola J., Cláudia M. Rocha, Daykin C. A., Dong J., Duarte I. F., Duarte I. F., Erol A., Fan T. W. M., Fiorenza A. M., Fiorenza A. M., Freedman D. S., Gao H., Gao H. C., Gu H. W., Haffner H. T., Heber D., Iola F. Duarte, Isabel M. Carreira, Joana Carrola, João Bernardo, Jordan K. W., Keun H. C., Kochhar S., Lai H.-S., Laiakis E. C., Lin L., Lina Carvalho, Liu M., Lokhov P. G., Ludwig C., Ma Y., MacIntyre D. A., Maeda J., Muntoni S., Naini A. B., Norton J. A., Okamoto N., Pirozynski M., Psychogios N., Qiu Y. P., Ritchie S. A., Rocha C. M., Sitter B., Spratlin J. L., Sreekumar A., Stringer K. A., Thysell E., Tiziani S., Travis W. D., Trygg J., Urayama S., Vitor Sousa, Xu Q. S., Xue R., Yin P., Zhang J. A., Zhang Z. Y., Zhou J., Zira A. N.   +66 more
core   +2 more sources

The Combination of Active‐Targeted Photodynamic Therapy and Photoactivated Chemotherapy for Enhanced Cancer Treatment

Journal of Biophotonics, Volume 18, Issue 6, June 2025.
Photoactivated chemotherapy (PACT), an oxygen‐independent light‐based therapy, utilizes chemotherapeutic regimens that remain inert until exposed to light, allowing target‐specific activation while minimizing off‐target toxicity. The integration of these techniques has the potential to improve selectivity and yield synergistic cytotoxic effects that ...
Nkune Williams Nkune, Heidi Abrahamse
wiley   +1 more source

Kussmaul's Sign Provoked by Intracardiac Metastasis of Endometrial Neuroendocrine Tumor

The Kaohsiung Journal of Medical Sciences, EarlyView.
Yi‐Hsun Chen, Chin‐Chuan Chang, Yao‐Kuang Wang, I‐Chen Wu   +3 more
wiley   +1 more source

Antagonism of 5‐HT7 Receptors as a Promising Target for Gastric Cancer via Apoptotic Pathway

Journal of Biochemical and Molecular Toxicology, Volume 39, Issue 6, June 2025.
Antagonism of 5‐HT7 receptors as an approach for combating gastric cancer through the apoptotic pathway is targeted. The present study aims to unearth potential avenues for advanced therapeutic strategies in the battle against this devastating disease by exploring the intricate interactions between 5‐HT7 receptors and gastric cancer, as well as ...
Irfan Cinar, Busra Dincer, Elif Cadirci, Salih Kara, Mehmet Ilhan Yildirgan, Zekai Halici, Saziye Sezin Palabiyik‐Yucelik   +6 more
wiley   +1 more source

Bronchial carcinoid tumors: second primary neoplasms and outcomes of surgical treatment

Jornal Brasileiro de Pneumologia
Objective: To analyze determinants of prognosis in patients with bronchial carcinoid tumors treated surgically and the potential concomitance of such tumors with second primary neoplasms.
Jefferson Luiz Gross, Marcel Adalid Tapia Vega, Guilherme Strambi Frenhi, Silvio Melo Torres, Antonio Hugo José Froes Marques Campos, Clovis Antonio Lopes Pinto, Felipe D’Almeida Costa, Fabio José Haddad   +7 more
doaj   +1 more source

Carcinoid syndrome: update on the pathophysiology and treatment

Clinics, 2018
Approximately 30-40% of patients with well-differentiated neuroendocrine tumors present with carcinoid syndrome, which is a paraneoplastic syndrome associated with the secretion of several humoral factors.
Anezka C. Rubin de Celis Ferrari, João Glasberg, Rachel P. Riechelmann   +2 more
doaj   +1 more source